Skip to the latest updates
Clintelo — Innovation IQ for PhysiciansClintelo
My Clintelo

Rheumatology. What changed.

New drugs and devices in rheumatology, newest first, each with its bottom line.

As of , Clintelo tracks 1 innovation in rheumatology: 1 drug (Lisraya (brepocitinib)). Each is written from the FDA's announcement or the developer's own release.

Drug IQ in Rheumatology

Search 1 in Drug IQ
  1. Drug IQFDA approvalLisraya (brepocitinib)Dermatomyositis · Priovant TherapeuticsAdults with dermatomyositis now have an FDA-approved oral therapy that improved disease activity scores over placebo at one year. It carries a boxed warning for serious infections, increased all-cause mortality, malignancies, major adverse cardiovascular events, and thrombosis.